<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37602529</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-2586</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of magnetic resonance imaging : JMRI</Title><ISOAbbreviation>J Magn Reson Imaging</ISOAbbreviation></Journal><ArticleTitle>Gray Matter Changes Following Mild COVID-19: An MR Morphometric Study in Healthy Young People.</ArticleTitle><Pagination><StartPage>2152</StartPage><EndPage>2161</EndPage><MedlinePgn>2152-2161</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmri.28970</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although COVID-19 is primarily an acute respiratory infection, 5%-40% of patients develop late and prolonged symptoms with frequent neurological complaints, known as long COVID syndrome. The presentation of the disease suggests that COVID infection may cause functional and/or morphological central nervous system alterations, but studies published in the literature report contradictory findings.</AbstractText><AbstractText Label="PURPOSE">To investigate the chronic effects of COVID-19 on cerebral grey matter in a group of young patients without comorbidities, with mild course of COVID infection and no medical complaints at the time of examination.</AbstractText><AbstractText Label="STUDY TYPE">Prospective.</AbstractText><AbstractText Label="POPULATION">Thirty-eight young (age&#x2009;=&#x2009;26.6&#x2009;&#xb1;&#x2009;5.0&#x2009;years; male/female&#x2009;=&#x2009;14/24), adult participants who recovered from mild COVID infection without a history of clinical long COVID and 37 healthy control subjects (age&#x2009;=&#x2009;25.9&#x2009;&#xb1;&#x2009;2.8&#x2009;years; male/female&#x2009;=&#x2009;14/23).</AbstractText><AbstractText Label="FIELD STRENGTH/SEQUENCE">Three Tesla, 3D T1-weighted magnetization-prepared rapid gradient-echo, 2D T2-weighted turbo spin-echo.</AbstractText><AbstractText Label="ASSESSMENT">MRI-based morphometry and volumetry along with neuropsychological testing and self-assessed questionnaire.</AbstractText><AbstractText Label="STATISTICAL TESTS">Fisher's exact test, Mann-Whitney U-test, and multiple linear regression analyses were used to assess differences between COVID and healthy control groups. P&#x2009;&lt;&#x2009;0.05 was used as cutoff for significance.</AbstractText><AbstractText Label="RESULTS">In the COVID group, significantly lower bilateral mean cortical thickness (left/right-hemisphere: 2.51&#x2009;&#xb1;&#x2009;0.06&#x2009;mm vs. 2.56&#x2009;&#xb1;&#x2009;0.07&#x2009;mm, &#x3b7;<sup>2</sup> <sub>p</sub>&#x2009;=&#x2009;0.102/2.50&#x2009;&#xb1;&#x2009;0.06&#x2009;mm vs. 2.54&#x2009;&#xb1;&#x2009;0.07&#x2009;mm, &#x3b7;<sup>2</sup> <sub>p</sub>&#x2009;=&#x2009;0.101), lower subcortical gray matter (57881&#x2009;&#xb1;&#x2009;3998&#x2009;mm<sup>3</sup> vs. 60470&#x2009;&#xb1;&#x2009;5211&#x2009;mm<sup>3</sup>, &#x3b7;<sup>2</sup> <sub>p</sub>&#x2009;=&#x2009;0.100) and lower right olfactory bulb volume (52.28&#x2009;&#xb1;&#x2009;13.55&#x2009;mm<sup>3</sup> vs. 60.98&#x2009;&#xb1;&#x2009;15.8&#x2009;mm<sup>3</sup>, &#x3b7;<sup>2</sup> <sub>p</sub>&#x2009;=&#x2009;0.078) were found. In patients with moderate to severe anosmia, cortical thickness was significantly lower bilaterally, as compared to patients without olfactory function loss (left/right-hemisphere: 2.50&#x2009;&#xb1;&#x2009;0.06&#x2009;mm vs. 2.56&#x2009;&#xb1;&#x2009;0.05&#x2009;mm, &#x3b7;<sup>2</sup>&#x2009;=&#x2009;0.173/2.49&#x2009;&#xb1;&#x2009;0.06&#x2009;mm vs. 2.55&#x2009;&#xb1;&#x2009;0.05&#x2009;mm, &#x3b7;<sup>2</sup>&#x2009;=&#x2009;0.189). Using further exploratory analysis, significantly reduced cortical thickness was detected locally in the right lateral orbitofrontal cortex in the COVID group (2.53&#x2009;&#xb1;&#x2009;0.10&#x2009;mm vs. 2.60&#x2009;&#xb1;&#x2009;0.09&#x2009;mm, &#x3b7;<sup>2</sup> <sub>p</sub>&#x2009;=&#x2009;0.112).</AbstractText><AbstractText Label="DATA CONCLUSION">Even without any subjective or objective neurological complaints at the time of the MR scan, subjects in the COVID group showed gray matter alterations in cortical thickness and subcortical gray matter volume.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">2 TECHNICAL EFFICACY: Stage 3.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perlaki</LastName><ForeName>G&#xe1;bor</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7690-6381</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ELKH-PTE Clinical Neuroscience MR Research Group, E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>P&#xe9;cs Diagnostic Centre, NeuroCT Ltd., P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darnai</LastName><ForeName>Gergely</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ELKH-PTE Clinical Neuroscience MR Research Group, E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Behavioural Sciences, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arat&#xf3;</LastName><ForeName>&#xc1;kos</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhour</LastName><ForeName>Husamalddin Ali</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szente</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;fra</LastName><ForeName>Eszter</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Behavioural Sciences, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Szilvia Anett</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ELKH-PTE Clinical Neuroscience MR Research Group, E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>P&#xe9;cs Diagnostic Centre, NeuroCT Ltd., P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Structural Neurobiology Research Group, Szent&#xe1;gothai Research Centre, University of Pecs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horv&#xe1;th</LastName><ForeName>R&#xe9;ka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kov&#xe1;cs</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xf3;czi</LastName><ForeName>Tam&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>P&#xe9;cs Diagnostic Centre, NeuroCT Ltd., P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orsi</LastName><ForeName>Gergely</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9388-2967</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ELKH-PTE Clinical Neuroscience MR Research Group, E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>P&#xe9;cs Diagnostic Centre, NeuroCT Ltd., P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janszky</LastName><ForeName>J&#xf3;zsef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of P&#xe9;cs, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ELKH-PTE Clinical Neuroscience MR Research Group, E&#xf6;tv&#xf6;s Lor&#xe1;nd Research Network, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TKP-2021-EGA-13</GrantID><Agency>Development and Innovation Fund of Hungary's Thematic Excellence Programmes</Agency><Country/></Grant><Grant><GrantID>TKP2021-EGA-16</GrantID><Agency>Development and Innovation Fund of Hungary's Thematic Excellence Programmes</Agency><Country/></Grant><Grant><GrantID>2017-1.2.1-NKP-2017-00002</GrantID><Agency>Hungarian Brain Research Program</Agency><Country/></Grant><Grant><Agency>Magyar Tudom&#xe1;nyos Akad&#xe9;mia</Agency><Country/></Grant><Grant><GrantID>K_22-142479</GrantID><Agency>OTKA</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Magn Reson Imaging</MedlineTA><NlmUniqueID>9105850</NlmUniqueID><ISSNLinking>1053-1807</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Magn Reson Imaging. 2024 Jun;59(6):2162-2163. doi: 10.1002/jmri.28999</RefSource><PMID Version="1">37670484</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="Y">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">cortical thickness</Keyword><Keyword MajorTopicYN="N">morphometry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37602529</ArticleId><ArticleId IdType="doi">10.1002/jmri.28970</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Cagnazzo F, Arquizan C, Derraz I, et al. Neurological manifestations of patients infected with the SARS&#x2010;CoV&#x2010;2: A systematic review of the literature. J Neurol 2021;268:2656&#x2010;2665.</Citation></Reference><Reference><Citation>Miyazato Y, Morioka S, Tsuzuki S, et al. Prolonged and late&#x2010;onset symptoms of coronavirus disease 2019. Open Forum Infect Dis 2020;7:2&#x2010;4.</Citation></Reference><Reference><Citation>Blomberg B, Mohn KG&#x2010;I, Brokstad KA, et al. Long COVID in a prospective cohort of home&#x2010;isolated patients. Nat Med 2021;27:1607&#x2010;1613.</Citation></Reference><Reference><Citation>Seang S, Itani O, Monsel G, et al. Long COVID&#x2010;19 symptoms: Clinical characteristics and recovery rate among non&#x2010;severe outpatients over a six&#x2010;month follow&#x2010;up. Infect Dis Now 2022;52:165&#x2010;169.</Citation></Reference><Reference><Citation>Robineau O, Zins M, Touvier M, et al. Long&#x2010;lasting symptoms after an acute COVID&#x2010;19 infection and factors associated with their resolution. JAMA Netw Open 2022;5:e2240985.</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID&#x2010;19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239&#x2010;1242.</Citation></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, et al. Immunoglobulin signature predicts risk of post&#x2010;acute COVID&#x2010;19 syndrome. Nat Commun 2022;13:446.</Citation></Reference><Reference><Citation>Lersy F, Bund C, Anheim M, et al. Evolution of neuroimaging findings in severe COVID&#x2010;19 patients with initial neurological impairment: An observational study. Viruses 2022;14:949.</Citation></Reference><Reference><Citation>Egbert AR, Cankurtaran S, Karpiak S. Brain abnormalities in COVID&#x2010;19 acute/subacute phase: A rapid systematic review. Brain Behav Immun 2020;89:543&#x2010;554.</Citation></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al. Cerebral micro&#x2010;structural changes in COVID&#x2010;19 patients &#x2013; An MRI&#x2010;based 3&#x2010;month follow&#x2010;up study. EClinicalMedicine 2020;25:100484.</Citation></Reference><Reference><Citation>Hafiz R, Gandhi TK, Mishra S, et al. Higher limbic and basal ganglia volumes in surviving COVID&#x2010;negative patients and the relations to fatigue. Neuroimage Rep 2022;2:100095.</Citation></Reference><Reference><Citation>Pelizzari L, Cazzoli M, Lipari S, et al. Mid&#x2010;term MRI evaluation reveals microstructural white matter alterations in COVID&#x2010;19 fully recovered subjects with anosmia presentation. Ther Adv Neurol Disord 2022;15:17562864221111996.</Citation></Reference><Reference><Citation>Niesen M, Trotta N, Noel A, et al. Structural and metabolic brain abnormalities in COVID&#x2010;19 patients with sudden loss of smell. Eur J Nucl Med Mol Imaging 2021;48:1890&#x2010;1901.</Citation></Reference><Reference><Citation>Ammar A, Distinguin L, Chetrit A, et al. Transient modifications of the olfactory bulb on MR follow&#x2010;up of COVID&#x2010;19 patients with related olfactory dysfunction. J Neuroradiol 2022;49:329&#x2010;332.</Citation></Reference><Reference><Citation>Frosolini A, Parrino D, Fabbris C, et al. Magnetic resonance imaging confirmed olfactory bulb reduction in long COVID&#x2010;19: Literature review and case series. Brain Sci 2022;12:430.</Citation></Reference><Reference><Citation>Tan CJ&#x2010;W, Tan BKJ, Tan XY, et al. Neuroradiological basis of COVID&#x2010;19 olfactory dysfunction: A systematic review and meta&#x2010;analysis. Laryngoscope 2022;132:1260&#x2010;1274.</Citation></Reference><Reference><Citation>Ismail II, Gad KA. Absent blood oxygen level&#x2013;dependent functional magnetic resonance imaging activation of the orbitofrontal cortex in a patient with persistent cacosmia and cacogeusia after COVID&#x2010;19 infection. JAMA Neurol 2021;78:609&#x2010;610.</Citation></Reference><Reference><Citation>Kim WSH, Ji X, Roudaia E, et al. Decreased cerebral blood flow in non&#x2010;hospitalized adults who self&#x2010;isolated due to COVID&#x2010;19. MedRxiv 2022.</Citation></Reference><Reference><Citation>Douaud G, Lee S, Alfaro&#x2010;Almagro F, et al. SARS&#x2010;CoV&#x2010;2 is associated with changes in brain structure in UK biobank. Nature 2022;604:697&#x2010;707.</Citation></Reference><Reference><Citation>Booth A, Reed AB, Ponzo S, et al. Population risk factors for severe disease and mortality in COVID&#x2010;19: A global systematic review and meta&#x2010;analysis. PLoS One 2021;16:e0247461.</Citation></Reference><Reference><Citation>Horv&#xe1;th RA, S&#xfc;t&#x151; Z, Cs&#xe9;ke B, et al. Epilepsy is overrepresented among young people who died from COVID&#x2010;19: Analysis of nationwide mortality data in Hungary. Seizure 2022;94:136&#x2010;141.</Citation></Reference><Reference><Citation>Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty&#x2010;five years of evaluation. Clin Psychol Rev 1988;8:77&#x2010;100.</Citation></Reference><Reference><Citation>Spielberger CD, Gonzalez&#x2010;Reigosa F, Martinez&#x2010;Urrutia A, Natalicio LFSS, Natalicio DS. The State&#x2010;Trait Anxiety Inventory. Int J Psychol 1971;5:145&#x2010;158.</Citation></Reference><Reference><Citation>Losonczi E, Bencsik K, Rajda C, Lencs&#xe9;s G, T&#xf6;r&#xf6;k M, V&#xe9;csei L. Validation of the fatigue impact scale in Hungarian patients with multiple sclerosis. Qual Life Res 2011;20:301&#x2010;306.</Citation></Reference><Reference><Citation>Oldfield RC. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 1971;9:97&#x2010;113.</Citation></Reference><Reference><Citation>Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological assessment. 5th ed. Oxford: Oxford University Press; 2012.</Citation></Reference><Reference><Citation>Jeong H, Lee J, Kim J, et al. Self&#x2010;assessment questionnaire for efficient and safe evaluation of patients with mild COVID&#x2010;19. Infect Chemother 2020;52:212&#x2010;215.</Citation></Reference><Reference><Citation>Rombaux P, Grandin C, Duprez T. How to measure olfactory bulb volume and olfactory sulcus depth? Acta Otorhinolaryngol Belg 2009;8:53.</Citation></Reference><Reference><Citation>Haehner A, Rodewald A, Gerber JC, Hummel T. Correlation of olfactory function with changes in the volume of the human olfactory bulb. Arch Otolaryngol Head Neck Surg 2008;134:621&#x2010;624.</Citation></Reference><Reference><Citation>Storsve AB, Fjell AM, Tamnes CK, et al. Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: Regions of accelerating and decelerating change. J Neurosci 2014;34:8488&#x2010;8498.</Citation></Reference><Reference><Citation>Blumen HM, Schwartz E, Allali G, et al. Cortical thickness, volume, and surface area in the motoric cognitive risk syndrome. J Alzheimers Dis 2021;81:651&#x2010;665.</Citation></Reference><Reference><Citation>Bernhardt BC, Chen Z, He Y, Evans AC, Bernasconi N. Graph&#x2010;theoretical analysis reveals disrupted small&#x2010;world organization of cortical thickness correlation networks in temporal lobe epilepsy. Cereb Cortex 2011;21:2147&#x2010;2157.</Citation></Reference><Reference><Citation>Pr&#xf6;bstel A&#x2010;K, Schirmer L. SARS&#x2010;CoV&#x2010;2&#x2010;specific neuropathology: Fact or fiction? Trends Neurosci 2021;44:933&#x2010;935.</Citation></Reference><Reference><Citation>Albornoz EA, Amarilla AA, Modhiran N, et al. SARS&#x2010;CoV&#x2010;2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol Psychiatry 2022;1&#x2010;16.</Citation></Reference><Reference><Citation>Piras IS, Huentelman MJ, Walker JE, et al. Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID&#x2010;19. medRxiv 2021.</Citation></Reference><Reference><Citation>Yus M, Matias&#x2010;Guiu JA, Gil&#x2010;Mart&#xed;nez L, et al. Persistent olfactory dysfunction after COVID&#x2010;19 is associated with reduced perfusion in the frontal lobe. Acta Neurol Scand 2022;146:194&#x2010;198.</Citation></Reference><Reference><Citation>Rolls ET, Cheng W, Feng J. The orbitofrontal cortex: Reward, emotion and depression. Brain Commun 2020;2:fcaa196.</Citation></Reference><Reference><Citation>Garcia&#x2010;Larrea L, Peyron R. Pain matrices and neuropathic pain matrices: A review. Pain 2013;154:S29&#x2010;S43.</Citation></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. 18F&#x2010;FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging 2021;48:2823&#x2010;2833.</Citation></Reference><Reference><Citation>Blazhenets G, Schroeter N, Bormann T, et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID&#x2010;19 patients. J Nucl Med 2021;62:910&#x2010;915.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>